Lv1
60 积分 2021-07-21 加入
Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial
4天前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
25天前
已完结
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
1个月前
已完结
Progresses of T-cell-engaging bispecific antibodies in treatment of solid tumors
2个月前
已完结
Dual-payload Antibody–drug Conjugates: Taking a Dual Shot
3个月前
已完结
Homogeneous multi-payload antibody–drug conjugates
3个月前
已完结
A prognostic model based on CLEC6A predicts clinical outcome of breast cancer patients
4个月前
已完结
Pharma deal making: a bright spot amid the gloom
4个月前
已完结
Topoisomerase I inhibitors: Challenges, progress and the road ahead
5个月前
已完结
Establishment of a novel prognostic signature based on an identified expression profile of integrin superfamily to predict overall survival of patients with colorectal adenocarcinoma
5个月前
已完结
皖公网安备34019202002308
